DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Franks LN, Ford BM, Fujiwara T. et al.
The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects.
Toxicol Appl Pharmacol 2018;
353: 31-42
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.